| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 7.71e-06 | 8 | 11 | 2 | GO:0047023 | |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 9.91e-06 | 9 | 11 | 2 | GO:0047044 | |
| GeneOntologyMolecularFunction | electron transfer activity | 3.72e-05 | 124 | 11 | 3 | GO:0009055 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 4.20e-05 | 18 | 11 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 7.56e-05 | 24 | 11 | 2 | GO:0004745 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 8.90e-05 | 26 | 11 | 2 | GO:0004022 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.03e-04 | 28 | 11 | 2 | GO:0051959 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 1.19e-04 | 30 | 11 | 2 | GO:0018455 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 1.44e-04 | 33 | 11 | 2 | GO:0033764 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.82e-04 | 37 | 11 | 2 | GO:0045505 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 2.02e-04 | 39 | 11 | 2 | GO:0016229 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 6.53e-04 | 70 | 11 | 2 | GO:0003777 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.84e-03 | 118 | 11 | 2 | GO:0003774 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 2.13e-03 | 127 | 11 | 2 | GO:0016616 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 2.50e-03 | 138 | 11 | 2 | GO:0016614 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | 7.37e-03 | 766 | 11 | 3 | GO:0016491 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 2.35e-02 | 441 | 11 | 2 | GO:0016887 | |
| GeneOntologyCellularComponent | dynein complex | 4.25e-04 | 54 | 12 | 2 | GO:0030286 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 6.87e-04 | 317 | 12 | 3 | GO:0032838 | |
| GeneOntologyCellularComponent | cytoplasmic region | 9.93e-04 | 360 | 12 | 3 | GO:0099568 | |
| GeneOntologyCellularComponent | microtubule associated complex | 3.70e-03 | 161 | 12 | 2 | GO:0005875 | |
| GeneOntologyCellularComponent | axoneme | 6.03e-03 | 207 | 12 | 2 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 6.09e-03 | 208 | 12 | 2 | GO:0097014 | |
| GeneOntologyCellularComponent | early endosome membrane | 6.32e-03 | 212 | 12 | 2 | GO:0031901 | |
| Domain | DHC_N2 | 3.43e-05 | 14 | 12 | 2 | PF08393 | |
| Domain | MT | 3.43e-05 | 14 | 12 | 2 | PF12777 | |
| Domain | Dynein_heavy_dom-2 | 3.43e-05 | 14 | 12 | 2 | IPR013602 | |
| Domain | ATPase_dyneun-rel_AAA | 3.43e-05 | 14 | 12 | 2 | IPR011704 | |
| Domain | AAA_8 | 3.43e-05 | 14 | 12 | 2 | PF12780 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.43e-05 | 14 | 12 | 2 | IPR024317 | |
| Domain | AAA_5 | 3.43e-05 | 14 | 12 | 2 | PF07728 | |
| Domain | Dynein_HC_stalk | 3.43e-05 | 14 | 12 | 2 | IPR024743 | |
| Domain | Dynein_heavy | 3.96e-05 | 15 | 12 | 2 | PF03028 | |
| Domain | DHC_fam | 3.96e-05 | 15 | 12 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 3.96e-05 | 15 | 12 | 2 | IPR004273 | |
| Domain | - | 1.51e-04 | 169 | 12 | 3 | 3.40.50.720 | |
| Domain | NAD(P)-bd_dom | 1.62e-04 | 173 | 12 | 3 | IPR016040 | |
| Domain | Sc_DH/Rdtase_CS | 2.23e-04 | 35 | 12 | 2 | IPR020904 | |
| Domain | ADH_SHORT | 5.12e-04 | 53 | 12 | 2 | PS00061 | |
| Domain | adh_short | 5.51e-04 | 55 | 12 | 2 | PF00106 | |
| Domain | SDR_fam | 5.72e-04 | 56 | 12 | 2 | IPR002347 | |
| Domain | AAA+_ATPase | 3.70e-03 | 144 | 12 | 2 | IPR003593 | |
| Domain | AAA | 3.70e-03 | 144 | 12 | 2 | SM00382 | |
| Pathway | REACTOME_THE_CANONICAL_RETINOID_CYCLE_IN_RODS_TWILIGHT_VISION | 6.84e-05 | 20 | 9 | 2 | MM14888 | |
| Pathway | REACTOME_THE_CANONICAL_RETINOID_CYCLE_IN_RODS_TWILIGHT_VISION | 9.10e-05 | 23 | 9 | 2 | M27174 | |
| Pubmed | 9.91e-06 | 14 | 12 | 2 | 9373155 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 8.60e-05 | 736 | 12 | 4 | 29676528 | |
| Pubmed | 2.68e-04 | 71 | 12 | 2 | 15760467 | ||
| Pubmed | The SDR (short-chain dehydrogenase/reductase and related enzymes) nomenclature initiative. | 2.83e-04 | 73 | 12 | 2 | 19027726 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 5.26e-03 | 423 | 12 | 2 | chr12q13 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 6.16e-04 | 76 | 9 | 2 | 743 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.62e-06 | 155 | 12 | 3 | 441fcb6d05364fc6f4973f0b973f1a80b573ce1f | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.51e-05 | 187 | 12 | 3 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175|Adult / Lineage, Cell type, age group and donor | 1.51e-05 | 187 | 12 | 3 | f3548817f2fded5978137bb252cb628ac199e4f6 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 1.56e-05 | 189 | 12 | 3 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | COVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.59e-05 | 190 | 12 | 3 | 07b675befcd1d0a9c90cb17b5d22323468325d51 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Mesothelial-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.82e-05 | 199 | 12 | 3 | 60a653100aff31f7f96796ff2ec634798bfb4b0d | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.99e-04 | 79 | 12 | 2 | a60fcbb278ba629af922c53faf58e4d96c537b15 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf-Oligodendrocyte.Trf.Ctps_(Ctps)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.99e-04 | 79 | 12 | 2 | 239d34f40c3a96186231f3aabd41c4988af3f372 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Pvrl3-Excitatory_Neuron.Slc17a7.Pvrl3-Fos_(CA3_Principal_cells)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.04e-04 | 80 | 12 | 2 | b661644806e225f215047e78ae46d7cee6efde4f | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf-Oligodendrocyte.Tfr.Ctps_(Ctps)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.58e-04 | 90 | 12 | 2 | 4d75217fd6b376bfda3300962cbe4875b31ffdaf | |
| ToppCell | COVID-19_Mild-Neutrophil-|COVID-19_Mild / Disease condition and Cell class | 4.73e-04 | 122 | 12 | 2 | 6ce3e9e2868d6cdc4ed90b90b2541b8f51270cac | |
| ToppCell | COVID-19_Mild-Neutrophil|COVID-19_Mild / Disease condition and Cell class | 4.73e-04 | 122 | 12 | 2 | bc4346f4caaed153583b0fe8521b45437f5c3049 | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.39e-04 | 142 | 12 | 2 | b66f9602dba30d1d4fbcc49ceb112eb5bd916ba1 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.48e-04 | 143 | 12 | 2 | 7a7a9829ba63468c9745904d9e993590051207ab | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.48e-04 | 143 | 12 | 2 | 990844ca674d30b2924c74b45bed4fdfb8463fa7 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.85e-04 | 147 | 12 | 2 | 64fa0753a3a79f492ef8acc6942bf90d379a983f | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.94e-04 | 148 | 12 | 2 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.94e-04 | 148 | 12 | 2 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | Ciliated_cells-A-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 7.22e-04 | 151 | 12 | 2 | 9d03ce73af15ef40c592d19b36aff46bebc14c40 | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.22e-04 | 151 | 12 | 2 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.22e-04 | 151 | 12 | 2 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 7.22e-04 | 151 | 12 | 2 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B0|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.22e-04 | 151 | 12 | 2 | 563439b0278776b82c1836c3de9fa80d1a4109af | |
| ToppCell | severe_COVID-19-NK_CD56bright|World / disease group, cell group and cell class (v2) | 7.32e-04 | 152 | 12 | 2 | ab5a4e47b23d16018642d4c9c7f41b30205edf73 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.32e-04 | 152 | 12 | 2 | 0652ee3443e6fbb679d2c4f326239ae7c803f924 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.32e-04 | 152 | 12 | 2 | ca23261d8ef263cc697b8d7e7cb2afec8bc564f2 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.51e-04 | 154 | 12 | 2 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.51e-04 | 154 | 12 | 2 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.51e-04 | 154 | 12 | 2 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.51e-04 | 154 | 12 | 2 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | 18-Distal-Immune-Immune|Distal / Age, Tissue, Lineage and Cell class | 7.51e-04 | 154 | 12 | 2 | ecfaed6fbffd1305a2216d48ecb33d8a182a9dd9 | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell-Peri|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.61e-04 | 155 | 12 | 2 | d8b5145258f075b15080f8739f537f48dd22225e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.61e-04 | 155 | 12 | 2 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.61e-04 | 155 | 12 | 2 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell-Peri-Peri_Kcnj8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.61e-04 | 155 | 12 | 2 | ced64e26962c5c6e6d539f361fe57ab0b399e999 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.61e-04 | 155 | 12 | 2 | 82e602f31981c6b48abff2a04b2ab5d26d4462a2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.61e-04 | 155 | 12 | 2 | 979c1d53b435a82c57d16707eed8ba7346326866 | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.61e-04 | 155 | 12 | 2 | 0f24ef6486aef354f0911c06932cb01d1a0525ac | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.71e-04 | 156 | 12 | 2 | 0b3630fd4479291599e1674e87eba6f93877ac3a | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.80e-04 | 157 | 12 | 2 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | severe_COVID-19-NK_CD56bright|severe_COVID-19 / disease group, cell group and cell class (v2) | 7.90e-04 | 158 | 12 | 2 | c2e8d96fc29aa2388b92b4fd81d2726e1f7a053f | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-04 | 158 | 12 | 2 | 2ef43d14ee65d004dc62c12ff209bbe12e4db681 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D122|Adult / Lineage, Cell type, age group and donor | 8.10e-04 | 160 | 12 | 2 | 0cfe130606af433b2aa90e0a20b6c44659dd6fd4 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 8.10e-04 | 160 | 12 | 2 | 19105debef96ea0c267d6a1d332303ec668ae47e | |
| ToppCell | Influenza_Severe-Neutrophil|Influenza_Severe / Disease group and Cell class | 8.20e-04 | 161 | 12 | 2 | 98c95b1b85d5427415af2ca8fb14849e97f6e8b5 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 8.31e-04 | 162 | 12 | 2 | 2259e9536147e9cdee772e3a30ba7d104573262c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.51e-04 | 164 | 12 | 2 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | droplet-Kidney-nan-18m-Lymphocytic-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-04 | 164 | 12 | 2 | 731b9c7d6f6ecfb14d4a8705e0ddac9fb460d9a8 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.82e-04 | 167 | 12 | 2 | a35ace2c722936d2a3e1f0826e5b6ec6b1340d2b | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 8.82e-04 | 167 | 12 | 2 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.82e-04 | 167 | 12 | 2 | 3e3d8f6df2feefafad5b44ba0ebf5b5a0fe4ed58 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.82e-04 | 167 | 12 | 2 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.82e-04 | 167 | 12 | 2 | 3ad9f3122dbe96580f640388ef920ea209fc2349 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.93e-04 | 168 | 12 | 2 | 03896466698a79f7f1ad862cb7e05585260e2a5a | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.93e-04 | 168 | 12 | 2 | 06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D122|Adult / Lineage, Cell type, age group and donor | 8.93e-04 | 168 | 12 | 2 | 8c3e1e45b422813bcdfa4273b1167db649a312f5 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.93e-04 | 168 | 12 | 2 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.93e-04 | 168 | 12 | 2 | 1002f058a340763e3d8de0bd1f0547a903526ec6 | |
| ToppCell | Influenza_Severe-Neutrophil|World / Disease group and Cell class | 9.03e-04 | 169 | 12 | 2 | 6e8e2580e19c96bcf7fa6a6d8c183df65f428396 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.03e-04 | 169 | 12 | 2 | 8bca402e144819cb9a8d431d6bf9429be2fff6d6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.03e-04 | 169 | 12 | 2 | 319cba07263bf41fcbcbfecd117f91b729394241 | |
| ToppCell | droplet-Lung-nan-18m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.03e-04 | 169 | 12 | 2 | f0f97ca415aef619b8b4b1399ad5e0823267516e | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.03e-04 | 169 | 12 | 2 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.03e-04 | 169 | 12 | 2 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.03e-04 | 169 | 12 | 2 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | CTRL-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | 9.14e-04 | 170 | 12 | 2 | 151dabe1d240dde414c881bf4fa816c69fa1c32d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.14e-04 | 170 | 12 | 2 | 5de2f7d16a05af74ebfb1ca42d0f9c3c3524692d | |
| ToppCell | droplet-Lung-18m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.14e-04 | 170 | 12 | 2 | 683c4aa74689791944b6f3998dba51a4456fbc49 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.24e-04 | 171 | 12 | 2 | 6a2f88c2a62cb2f69797804e24eb1137a3e148de | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122|Adult / Lineage, Cell type, age group and donor | 9.24e-04 | 171 | 12 | 2 | bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.24e-04 | 171 | 12 | 2 | 1597459c971d6befa991d59dc66b41b6a522f797 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.24e-04 | 171 | 12 | 2 | 9be3554626408bb897d1f1c43b3ab4a92651f2e2 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.24e-04 | 171 | 12 | 2 | fd59ac4a39748840b2ee1c930ea475433ff61485 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-epithelial_cell_of_lung|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.24e-04 | 171 | 12 | 2 | d382430e5cdd0f2aac4fc093d8fe8d66efb4629b | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.24e-04 | 171 | 12 | 2 | 4347e6f62c04ea43299893ad4b79719049009a56 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.24e-04 | 171 | 12 | 2 | d5960b40ad5b87aaa00c93a6b31cdf41cc4f1375 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.24e-04 | 171 | 12 | 2 | b3e6e31dfe3623b960ccf692fdbd236fa4039923 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.35e-04 | 172 | 12 | 2 | 1ef243bce63d841c25e4b74d029d1377f84bcc3d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.35e-04 | 172 | 12 | 2 | ab1c81be29f93ca8920c6ab5ab92f497a9256d3f | |
| ToppCell | CTRL-Myeloid-Neutrophil|CTRL / Disease state, Lineage and Cell class | 9.35e-04 | 172 | 12 | 2 | ef3a6fe3b7300959f9f71130200c7fb8741c42b0 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 9.46e-04 | 173 | 12 | 2 | e05cddf5bf63cf419343ff229453327519765be8 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.46e-04 | 173 | 12 | 2 | d78397e65e997ddb995111a810f0e2a4f67d0765 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 9.46e-04 | 173 | 12 | 2 | 74ad5ed33821b8816c9c8e67c50ee4496ba18e2f | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.46e-04 | 173 | 12 | 2 | 3c852ffe22f4a5b632463086b08c669310684e80 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 9.46e-04 | 173 | 12 | 2 | ef8d720b99470fe1953661f6e66bc0366266bdb6 | |
| ToppCell | severe_influenza-Neutrophil|severe_influenza / disease group, cell group and cell class (v2) | 9.46e-04 | 173 | 12 | 2 | 615e266419b9f06e964eff73cb466f05451ba0dd | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.46e-04 | 173 | 12 | 2 | 9a2d42f8d9cb834856522661d524abb91c4637c5 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 9.57e-04 | 174 | 12 | 2 | 110369f6b78de34a6d934b5b47cecd023347bc80 | |
| ToppCell | facs-Heart-RA-24m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.57e-04 | 174 | 12 | 2 | 42dfb6f42b72e40e203b3ef341117bccf3553d54 | |
| ToppCell | facs-Heart-RA-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.57e-04 | 174 | 12 | 2 | f04edf2ca6788875c9918611e416fb739924382e | |
| ToppCell | COVID-19-kidney-PCT-S3-2|kidney / Disease (COVID-19 only), tissue and cell type | 9.57e-04 | 174 | 12 | 2 | 5aa2fb631505600f37d2b87b02def7be139dc262 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.57e-04 | 174 | 12 | 2 | b3cd22e717d178269e6d5bd5ed7b2d945cd8ea25 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.57e-04 | 174 | 12 | 2 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | COVID-19-kidney-PCT-S3-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.79e-04 | 176 | 12 | 2 | b6497324e3e52f514ce556a3fa0c3011c45dcc7b | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein|Adult / Lineage, Cell type, age group and donor | 9.79e-04 | 176 | 12 | 2 | 043683c61c5d1a7f8a4666a612310246bd3d83a2 | |
| ToppCell | Ciliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 9.90e-04 | 177 | 12 | 2 | c38138fb5ad9766c2d240811210c854338cd612e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Neutrophil|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.90e-04 | 177 | 12 | 2 | ed44b1bf2ffae97f94e944d1b6060d5163eba6a6 | |
| ToppCell | facs-Kidney-nan-18m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-04 | 177 | 12 | 2 | d4cd54c07f1e51b5485270348fb7195d53465027 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.00e-03 | 178 | 12 | 2 | ad6dc4a375664c919bd48c35c48a561fc5a7de8c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.00e-03 | 178 | 12 | 2 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| Computational | Neighborhood of IGF1 | 1.17e-04 | 26 | 7 | 2 | GNF2_IGF1 | |
| Computational | Neighborhood of CYP2B6 | 4.21e-04 | 49 | 7 | 2 | GNF2_CYP2B6 | |
| Computational | Neighborhood of CEBPA | 7.19e-04 | 64 | 7 | 2 | GNF2_CEBPA | |
| Computational | Neighborhood of TST | 1.89e-03 | 104 | 7 | 2 | GNF2_TST | |
| Computational | Neighborhood of GSTM1 | 2.07e-03 | 109 | 7 | 2 | GNF2_GSTM1 | |
| Computational | Neighborhood of LCAT | 2.67e-03 | 124 | 7 | 2 | GNF2_LCAT | |
| Computational | Neighborhood of HPN | 3.11e-03 | 134 | 7 | 2 | GNF2_HPN | |
| Computational | Neighborhood of HPX | 3.16e-03 | 135 | 7 | 2 | GNF2_HPX | |
| Computational | Neighborhood of MAP4K4 | 5.07e-03 | 172 | 7 | 2 | GCM_MAP4K4 | |
| Drug | Androstane-3,17-diol | 3.88e-05 | 18 | 12 | 2 | ctd:D015113 | |
| Drug | 3,4-didehydroretinoic acid | 3.88e-05 | 18 | 12 | 2 | CID000447276 | |
| Drug | Racecadotril [81110-73-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 1.27e-04 | 194 | 12 | 3 | 5755_DN | |
| Drug | alpha-Santonin [481-06-1]; Up 200; 16.2uM; PC3; HT_HG-U133A | 1.27e-04 | 194 | 12 | 3 | 4531_UP | |
| Drug | Asiaticoside [16830-15-2]; Down 200; 4.2uM; MCF7; HT_HG-U133A | 1.29e-04 | 195 | 12 | 3 | 7004_DN | |
| Drug | Telenzepine dihydrochloride [147416-96-4]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.31e-04 | 196 | 12 | 3 | 7419_DN | |
| Drug | Ascorbic acid [50-81-7]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 1.31e-04 | 196 | 12 | 3 | 5407_UP | |
| Drug | Clemastine fumarate [14976-57-9]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.31e-04 | 196 | 12 | 3 | 7485_DN | |
| Drug | Quinidine hydrochloride monohydrate [6151-40-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.31e-04 | 196 | 12 | 3 | 6267_DN | |
| Drug | Diethylcarbamazine citrate [1642-54-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.33e-04 | 197 | 12 | 3 | 7425_DN | |
| Drug | troglitazone; Up 200; 10uM; SKMEL5; HG-U133A | 1.33e-04 | 197 | 12 | 3 | 504_UP | |
| Drug | Antipyrine, 4-hydroxy [1672-63-5]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 1.33e-04 | 197 | 12 | 3 | 1497_DN | |
| Drug | Dropropizine (R,S) [17692-31-8]; Down 200; 17uM; MCF7; HT_HG-U133A | 1.35e-04 | 198 | 12 | 3 | 5531_DN | |
| Drug | Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Down 200; 21uM; PC3; HT_HG-U133A | 1.35e-04 | 198 | 12 | 3 | 4078_DN | |
| Drug | Carisoprodol [78-44-4]; Up 200; 15.4uM; PC3; HT_HG-U133A | 1.35e-04 | 198 | 12 | 3 | 6610_UP | |
| Drug | MK-886; Down 200; 1uM; MCF7; HG-U133A | 1.37e-04 | 199 | 12 | 3 | 264_DN | |
| Drug | tetraethylenepentamine pentahydrochloride; Up 200; 100uM; HL60; HG-U133A | 1.37e-04 | 199 | 12 | 3 | 412_UP | |
| Drug | Biliton | 2.06e-04 | 41 | 12 | 2 | CID000002974 | |
| Drug | triethylamine | 3.08e-04 | 50 | 12 | 2 | CID000008471 | |
| Drug | 4-(4-(2,4-dioxothiazolidin-5-ylidenemethyl)-2-methoxyphenoxy)-3-trifluoromethylbenzonitrile | 3.72e-04 | 55 | 12 | 2 | ctd:C575631 | |
| Drug | anethole trithione | 4.89e-04 | 63 | 12 | 2 | CID000002194 | |
| Drug | N,N-dimethylproline | 5.20e-04 | 65 | 12 | 2 | CID000000554 | |
| Drug | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester | 6.18e-04 | 807 | 12 | 4 | ctd:C548651 | |
| Drug | NAD | 7.87e-04 | 80 | 12 | 2 | ctd:D009243 | |
| Drug | 5 alpha-androstane | 8.67e-04 | 84 | 12 | 2 | CID000094144 | |
| Drug | olmesartan | 1.02e-03 | 91 | 12 | 2 | CID000158781 | |
| Drug | IC261 | 1.13e-03 | 96 | 12 | 2 | CID000003674 | |
| Drug | 3-hydroxyandrostan-17-one | 1.27e-03 | 102 | 12 | 2 | CID000000225 | |
| Drug | flufenamic acid | 1.43e-03 | 108 | 12 | 2 | CID000003371 | |
| Drug | AC1L1IZE | 2.09e-03 | 131 | 12 | 2 | CID000004799 | |
| Drug | dihydrochloride | 3.05e-03 | 159 | 12 | 2 | CID000070978 | |
| Drug | androstan-3-ol | 3.09e-03 | 160 | 12 | 2 | CID000092877 | |
| Drug | Ellipticine [519-23-3]; Up 200; 16.2uM; PC3; HT_HG-U133A | 3.81e-03 | 178 | 12 | 2 | 5779_UP | |
| Drug | deferoxamine mesylate salt; Up 200; 100uM; MCF7; HG-U133A | 4.06e-03 | 184 | 12 | 2 | 573_UP | |
| Drug | 5224221; Down 200; 12uM; MCF7; HT_HG-U133A_EA | 4.15e-03 | 186 | 12 | 2 | 839_DN | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 4.15e-03 | 186 | 12 | 2 | 5597_UP | |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Up 200; 13uM; PC3; HT_HG-U133A | 4.20e-03 | 187 | 12 | 2 | 4207_UP | |
| Drug | 15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A | 4.20e-03 | 187 | 12 | 2 | 6948_DN | |
| Drug | CP-690334-01 [459212-38-5]; Up 200; 10uM; PC3; HT_HG-U133A | 4.24e-03 | 188 | 12 | 2 | 3823_UP | |
| Drug | geldanamycin; Down 200; 1uM; HL60; HT_HG-U133A | 4.24e-03 | 188 | 12 | 2 | 6187_DN | |
| Drug | 11-cis-retinal | 4.28e-03 | 189 | 12 | 2 | CID000001070 | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 4.28e-03 | 189 | 12 | 2 | 1643_DN | |
| Drug | carbamazepine; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 4.33e-03 | 190 | 12 | 2 | 952_UP | |
| Drug | CID11987713 | 4.33e-03 | 190 | 12 | 2 | CID011987713 | |
| Drug | tyrphostin AG-825; Up 200; 25.2uM; MCF7; HT_HG-U133A_EA | 4.33e-03 | 190 | 12 | 2 | 1114_UP | |
| Drug | 17-AAG; Down 200; 1uM; HL60; HT_HG-U133A | 4.37e-03 | 191 | 12 | 2 | 2678_DN | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; HL60; HG-U133A | 4.37e-03 | 191 | 12 | 2 | 1417_UP | |
| Disease | serine measurement | 8.95e-05 | 35 | 12 | 2 | EFO_0009774 | |
| Disease | age at menopause | 2.18e-04 | 302 | 12 | 3 | EFO_0004704 | |
| Disease | migraine disorder | 3.56e-04 | 357 | 12 | 3 | MONDO_0005277 | |
| Disease | migraine disorder, Headache | 5.44e-04 | 86 | 12 | 2 | HP_0002315, MONDO_0005277 | |
| Disease | urinary uromodulin measurement | 6.77e-04 | 96 | 12 | 2 | EFO_0005663 | |
| Disease | lifestyle measurement, anxiety disorder measurement | 1.37e-03 | 137 | 12 | 2 | EFO_0007795, EFO_0010724 | |
| Disease | phospholipid measurement | 1.43e-03 | 140 | 12 | 2 | EFO_0004639 | |
| Disease | sphingomyelin measurement | 5.48e-03 | 278 | 12 | 2 | EFO_0010118 | |
| Disease | phosphatidylcholine measurement | 5.72e-03 | 284 | 12 | 2 | EFO_0010226 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ITWILLLRYYIHLQR | 2796 | Q96N23 | |
| LYRHWIEIVLLYRTY | 381 | O95256 | |
| LESLYRLLWVYVIRI | 356 | O94915 | |
| LYYLLHWYRERQVVS | 11 | O14756 | |
| YIEDWVIVHRRYQYL | 116 | Q96HP0 | |
| RLWIHEVYRVFYDRL | 2301 | Q8TD57 | |
| LERYIQRYLVYAILW | 2486 | Q14204 | |
| YWEHRTRVGRLYAVY | 336 | O43541 | |
| LYYLLHWYRERQVLS | 11 | O75452 | |
| QYRSRYLILYAAWLV | 56 | Q4KMZ8 | |
| VIYCVNIIYWYIRLL | 996 | Q9HCF6 | |
| LYTLVIPIRYYVRWR | 306 | Q687X5 |